SILLAJEN
Live / Applied — First extension granted (statement of use) (as of 24 Sept 2025)
What this means for you
Not registered yet, but its 09 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97926910
- Mark type
- Stylized text
- Filed
- 09 May 2023
- Published for opposition
- 28 Jan 2025
- Attorney of record
- Alicia Morris Groos
Goods and services
- Class 005 — Pharmaceuticals: Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer
- Class 042 — Scientific and technological services: Providing information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer
Owner
- SillaJen, Inc., Seoul, KR
- SillaJen, Inc., Seoul, KR
Prosecution history
- 18 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 17 Oct 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 24 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Sept 2025 — SOU EXTENSION 1 GRANTED
- 23 Sept 2025 — SOU EXTENSION 1 FILED
- 23 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2025 — PUBLISHED FOR OPPOSITION
- 22 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Feb 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 09 Feb 2024 — LETTER OF SUSPENSION E-MAILED
- 09 Feb 2024 — SUSPENSION LETTER WRITTEN